Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications (Q37107174)

18 August 2017

1 reference

title

Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications (English)

1 reference

18 August 2017

0 references

3

Ann Marie Schmidt

1 reference

18 August 2017

Shi Fang Yan

1

1 reference

PubMed ID

18332897

18 August 2017

Ravichandran Ramasamy

series ordinal

2

1 reference

18 August 2017

11 March 2008

1 reference

Nature Clinical Practice Endocrinology and Metabolism

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

285-293

1 reference

18 August 2017

5

1 reference

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Glycation products and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

The RAGE axis in early diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-ac

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0786

7 January 2021

Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.2337/DB07-0339

Identifiers

DOI

10.1038/NCPENDMET0786

1 reference

18 August 2017

1 reference

PubMed ID

18332897